Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-21-047306
Filing Date
2021-09-10
Accepted
2021-09-10 08:01:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea147025-424b4_180lifesci.htm 424B4 2733681
2 GRAPHIC image_001.jpg GRAPHIC 105237
3 GRAPHIC image_002.jpg GRAPHIC 53102
4 GRAPHIC image_003.jpg GRAPHIC 18163
5 GRAPHIC image_004.jpg GRAPHIC 41661
  Complete submission text file 0001213900-21-047306.txt   3035693
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-259209 | Film No.: 211245887
SIC: 2834 Pharmaceutical Preparations